Trade Cabaletta Bio, Inc. - CABA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0322 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024929% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002707% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 3.6989 |
Open | 3.6889 |
1-Year Change | -76.86% |
Day's Range | 3.6889 - 4.0389 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 4, 2024 | 3.9689 | 0.2800 | 7.59% | 3.6889 | 4.0589 | 3.6489 |
Nov 1, 2024 | 3.6989 | 0.2300 | 6.63% | 3.4689 | 3.7689 | 3.4689 |
Oct 31, 2024 | 3.5289 | -0.2400 | -6.37% | 3.7689 | 3.7889 | 3.5289 |
Oct 30, 2024 | 3.7689 | -0.3500 | -8.50% | 4.1189 | 4.1889 | 3.7489 |
Oct 29, 2024 | 4.1789 | 0.1400 | 3.47% | 4.0389 | 4.2089 | 3.9889 |
Oct 28, 2024 | 4.0789 | 0.1400 | 3.55% | 3.9389 | 4.2489 | 3.8989 |
Oct 25, 2024 | 3.8989 | 0.0500 | 1.30% | 3.8489 | 4.0089 | 3.8389 |
Oct 24, 2024 | 3.8389 | -0.2000 | -4.95% | 4.0389 | 4.0889 | 3.8189 |
Oct 23, 2024 | 4.0189 | -0.1800 | -4.29% | 4.1989 | 4.3089 | 3.9589 |
Oct 22, 2024 | 4.2689 | -0.1400 | -3.18% | 4.4089 | 4.5589 | 4.2189 |
Oct 21, 2024 | 4.4989 | -0.3000 | -6.25% | 4.7989 | 4.8889 | 4.2689 |
Oct 18, 2024 | 4.8889 | 0.0300 | 0.62% | 4.8589 | 4.9189 | 4.6589 |
Oct 17, 2024 | 4.8389 | 0.2100 | 4.54% | 4.6289 | 4.8589 | 4.5289 |
Oct 16, 2024 | 4.6589 | 0.3300 | 7.62% | 4.3289 | 4.6689 | 4.1989 |
Oct 15, 2024 | 4.3089 | 0.0700 | 1.65% | 4.2389 | 4.3689 | 4.1589 |
Oct 14, 2024 | 4.2389 | 0.1400 | 3.42% | 4.0989 | 4.3489 | 4.0889 |
Oct 11, 2024 | 4.1889 | 0.3000 | 7.71% | 3.8889 | 4.2889 | 3.8389 |
Oct 10, 2024 | 3.9389 | -0.2300 | -5.52% | 4.1689 | 4.1689 | 3.8189 |
Oct 9, 2024 | 4.1189 | -0.0600 | -1.44% | 4.1789 | 4.2889 | 4.0289 |
Oct 8, 2024 | 4.3089 | 0.3100 | 7.75% | 3.9989 | 4.4289 | 3.9589 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cabaletta Bio, Inc. Company profile
About Cabaletta Bio Inc
Cabaletta Bio Inc. is a clinical-stage biotechnology company. The Company is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. The Company's lead CAAR T cell product candidate is designed based on chimeric antigen receptor (CAR), and its T cell technology has been developed and is marketed for the treatment of B cell cancers. The Company has discovered and developed four product candidates, including its lead product candidate, to potentially treat patients with mucosal pemphigus vulgaris (mPV), and three additional product candidates that have demonstrated specific and selective target engagement in vitro. Its product pipelines include DSG3-CAART, DSG3/1-CAART, Musk-CAART and FVIII-CAART.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cabaletta Bio Inc revenues was not reported. Net loss increased 39% to $46.3M. Higher net loss reflects Research and development increase of 53% to $29.7M (expense), Stock-based Compensation in R&D increase of 38% to $2.7M (expense), General and administrative increase of 7% to $10.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.44 to -$1.80.
Industry: | Bio Therapeutic Drugs |
2929 Arch Street
Suite 600
PHILADELPHIA
PENNSYLVANIA 19104
US
News
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024Gold markets to trade
Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.
08:00, 21 October 2024US earnings seasons off to a solid start as focus shifts to tech giants
The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.
14:31, 17 October 2024ECB Preview: cooling growth and inflation call for another rate cut
Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.
12:41, 16 October 2024Australian labour force data forecast to reveal stable jobs market
Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.
07:41, 15 October 2024Applying fundamental and technical strategies to Gold Trading
Last week, we visualised the key potential drivers of gold in a chart focused on recent performance. Understanding the factors that can move gold prices is essential, but translating that knowledge into effective trading strategies is where the real potential can lie.
08:00, 14 October 2024People also watch
Still looking for a broker you can trust?
Join the 650,000+ traders worldwide that chose to trade with Capital.com